Dr. Mary Claire Haver on Hormone Therapy, Menopause, and Women's Health Research Funding

Hormone Replacement Therapy Update

• 💡 The FDA has removed the black box warning for hormone replacement therapy (HRT) for menopause symptoms, acknowledging that for most women, the benefits outweigh potential risks.
• ⚠️ This decision, achieved after decades of advocacy, revises the outdated interpretation of the Women's Health Initiative study, particularly for local estrogen products which are not systemically absorbed.
• 📌 While general warnings for all medications remain, the removal of the overly dramatic black box warning signifies a major shift in understanding HRT.

Expanding Focus Beyond Hot Flashes

• 🎯 Research on menopause is increasingly focusing on its cardioabolic and neurologic impacts, moving beyond just hot flash relief.
• 🧠 Losing estrogen affects all organ systems, with new research highlighting impacts on cardiovascular disease, visceral fat, insulin resistance, bone loss, and cognitive aging.
• 💬 Social media discussions have prompted researchers to investigate less-discussed symptoms like frozen shoulder, palpitations, and tinnitus during menopause.

Perimenopause Research and Recognition

• 📈 Perimenopause research is surging, though it lags significantly behind menopause research, with only about 7,000 articles compared to 98,000 for menopause.
• ⚠️ Many women in perimenopause are misdiagnosed, with symptoms attributed to psychological issues rather than hormonal changes, leading to inappropriate antidepressant prescriptions.
• 🧠 Stabilizing hormones during perimenopause can lead to better cognitive and mental health outcomes, often more effectively than starting with antidepressants.
• ⏳ Perimenopause can last up to 10 years, and HRT during this time can be particularly beneficial for mental health.

Funding Crisis and Innovation in Women's Health

• 💰 Women's health research has historically received significantly less funding than male-dominated diseases, with federal investment stagnating.
• 📈 Despite the funding crisis, private entities like Melinda French Gates are stepping up, committing substantial funds to women's health innovation.
• 👩‍⚕️ There's a critical shortage of clinicians trained in menopause care, leading to companies investing in menopause benefits, time off, and resources for employees.

Access to Care and Telemedicine

• 📉 Major cuts to Medicaid spending in rural communities exacerbate the existing struggle for women to access adequate healthcare providers and expertise.
• 💻 Telemedicine companies are emerging as a crucial solution, specifically designed to serve women in perimenopause and menopause, improving access to care in underserved areas.